Skip to content
10-K

Annual Report

Amgen Inc. AMGN

0000318154-25-000010

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 11, 2025 537.2M sh
Long Term Debt FY 2024 · Dec 31, 2023 $63.17B
Cash And Equivalents FY 2024 · Dec 31, 2023 $10.94B
Current Liabilities FY 2024 · Dec 31, 2023 $18.39B
Current Assets FY 2024 · Dec 31, 2023 $30.33B
Total Assets FY 2024 · Dec 31, 2023 $97.15B
Shares Diluted FY 2024 · Dec 31, 2022 541M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $6.36B
Dividends Paid FY 2024 · Dec 31, 2022 $4.2B
Capex FY 2024 · Dec 31, 2022 $936M
Operating Cash Flow FY 2024 · Dec 31, 2022 $9.72B
Eps Diluted FY 2024 · Dec 31, 2022 $12.11
Eps Basic FY 2024 · Dec 31, 2022 $12.18
Sga Expense FY 2024 · Dec 31, 2022 $5.41B
Net Income FY 2024 · Dec 31, 2022 $6.55B
Operating Income FY 2024 · Dec 31, 2022 $9.57B
Cost Of Revenue FY 2024 · Dec 31, 2022 $6.41B
Revenue FY 2024 · Dec 31, 2022 $26.32B
Stockholders Equity FY 2024 · Dec 31, 2021 $6.7B